Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Cancer Prev Res (Phila). 2016 Mar 7;9(5):396–405. doi: 10.1158/1940-6207.CAPR-15-0380

Table 1.

Distributions of demographics and lifestyle factors and glutathione-S-transferase (GST) genotypes of study subjects by the treatment sequence assignment The PEITC Intervention Study 2008–2013

Characteristics at baselinea Treatment sequence assignment
Total
PEITC-Placebo Placebo-PEITC Pb
Number of subjects 41 41 82
Age (years), mean (SD) 40.9 (10.6) 41.1 (9.6) 0.939 41.0 (10.1)
Body mass index (kg/m2), mean (SD) 28.0 (4.8) 28.0 (6.3) 0.957 28.0 (5.6)
Gender, n (%) 0.376
 Male 24 (59) 20 (49) 44 (54)
 Female 17 (41) 21 (51) 38 (46)
Race, n (%) 0.839
 Africa American 8 (20) 10 (24) 18 (22)
 Caucasian American 28 (68) 27 (66) 55 (67)
 Others 5 (12) 4 (10) 9 (11)
Level of education, n (%) 0.179
 High school or lower 14 (34) 20 (49) 34 (41)
 College or higher 27 (66) 21 (51) 48 (59)
Cigarette smoking, mean (SD)
 Cigarettes/day 19.3 (6.6) 19.0 (6.7) 0.843 19.1 (6.6)
 Years of smoking 14.7 (10.3) 17.9 (9.4) 0.157 16.3 (9.8)
 Age at starting smoking (year) 15.2 (4.9) 15.1 (4.6) 0.963 15.1 (4.7)
 Age became regular smokers (year) 18.6 (7.1) 17.7 (5.2) 0.514 18.1 (6.2)
Alcohol drinking, n (%) 0.784
 Never 14 (35) 17 (42) 31 (39)
 Monthly or less 14 (35) 12 (30) 26 (32)
 Greater than monthly 12 (30) 11 (28) 23 (29)
GSTM1 & GSTT1 genotypes, n (%) 0.585
 Both present 20 (49) 18 (44) 38 (46)
 Present/null 3 (7) 4 (10) 7 (9)
 Null/present 14 (34) 11 (27) 25 (30)
 Both null 4 (10) 8 (19) 12 (15)
a

Abbreviations: SD, standard deviation.

b

2-sided P for the difference between the two treatment assignment groups based on the two-group t-test (for continuous variables) or χ2 test (for nominal or categorical variables).

Two subjects were excluded from this analysis due to missing data.